Evidence map›Paper›PMID 33912742›Full record

ArticleKidney international reports2021

A New Chemiluminescence Immunoassay for Phospholipase A

Elion Hoxha, Rolf A K Stahl, Linda Reinhard, Alexander Kühnl, Wolfgang Schlumberger, Cornelia Dähnrich

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Elion HoxhaIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Rolf A K StahlIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Linda ReinhardIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Alexander KühnlInstitute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany.
Wolfgang SchlumbergerInstitute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany.
Cornelia DähnrichInstitute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany.
Euroimmun Medizinische Labordiagnostika (Germany) · DEUniversität Hamburg · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCirculating autoantibodies against the M-type phospholipase A

methodsSerum samples from patients with biopsy-proven MN and disease controls were analyzed for PLA

resultsThe ChLIA demonstrated almost perfect agreement with RC-IFA for the identification of patients with PLA

conclusionsThe PLA

Indexed as

chemiluminescence immunoassaymembranous nephropathyphospholipase A2 receptor 1PLA2R1-abrenal autoimmune diseases

Identifiers

PMID33912742
PMCPMC8071618
OpenAlexW3120799332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.